drugset / Trial / NCT00406250
Intravitreal Bevacizumab in Agioid Streaks
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety and efficacy of intravitreal bevacizumab in patients with choroidal neovascularization associated with angioid streaks.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-12
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |